Dr. Babak Saboury

Dr. Babak Saboury, MD, MPH, DABR, DABNM, is a renowned physician-scientist recognized for his pioneering contributions at the intersection of nuclear medicine, radiopharmaceutical therapy, and artificial intelligence (AI). As the Co-Founder and Chief Innovation Officer at United Theranostics, he spearheads transformative initiatives that integrate advanced imaging technologies with AI-driven analytics to advance personalized cancer care.

A dedicated onco-radiologist and nuclear medicine physician, Dr. Saboury has long championed the clinical adoption of precision medicine. His work is grounded in a commitment to harnessing molecular imaging and theranostics to deliver more targeted, effective treatments for cancer patients. His expertise spans a wide range of applications—from diagnostic innovation to therapeutic development—anchored by a vision to bring nuclear medicine to the forefront of modern oncology.

In addition to his innovation leadership, Dr. Saboury serves as the Executive and Medical Director of Clinical Trials at United Theranostics. In this role, he oversees the design, implementation, and execution of early- and late-phase clinical research, helping to drive the translation of promising radiopharmaceuticals from bench to bedside. His passion for clinical trials stems from a deep belief in evidence-based advancement and his desire to accelerate access to cutting-edge therapies for patients.

Dr. Saboury continues to be a driving force in redefining how cancer is diagnosed and treated, using molecular insights to personalize therapy and improve outcomes. Through his leadership at United Theranostics, he remains committed to shaping the future of nuclear medicine and expanding its role in the broader landscape of precision oncology.

More Details

Educational Background and Early Career

Dr. Saboury earned his Doctor of Medicine (MD) and Master of Public Health (MPH) degrees from Tehran University of Medical Sciences. He subsequently completed a combined residency in diagnostic radiology and nuclear medicine at the University of Maryland Medical Center, where he trained under esteemed mentors Dr. Eliot Siegel and Dr. Vaskin Dilsizian. Following his residency, he served as an attending radiologist and nuclear medicine physician at the University of Maryland until 2019, laying a robust foundation for his multidisciplinary career.

Clinical Leadership and Innovation

At United Theranostics, Dr. Saboury spearheads the integration of cutting-edge technologies into clinical practice. His leadership focuses on enhancing patient care through the application of AI, quantitative imaging biomarkers, and personalized radiopharmaceutical therapies. Previously, at the National Institutes of Health Clinical Center, he held multiple leadership roles, including Chief Clinical Data Science Officer and Lead Radiologist for PET/MRI. In these capacities, he directed initiatives in radiomics, radiogenomics, and precision dosimetry, contributing significantly to the advancement of personalized medicine.

Research Contributions and Publications

Dr. Saboury’s research portfolio is extensive, encompassing over 240 publications with more than 7,900 citations. His work primarily focuses on the integration of AI in nuclear medicine, development of quantitative imaging biomarkers, and optimization of radiopharmaceutical therapies. Notable publications include studies on ultra-low-dose PET scan protocols, computational modeling of 177Lu-PSMA therapy, and the role of AI in PET/CT imaging for lymphoma management. ResearchGate

He has also contributed to seminal reports such as “The Bethesda Report (AI Summit 2024)” and “Issues and Challenges in Applications of Artificial Intelligence to Nuclear Medicine,” which outline the current landscape and future directions of AI integration in nuclear medicine.

Editorial and Advisory Roles

Dr. Saboury serves on the editorial board of Frontiers in Medicine in the Nuclear Medicine section, where he contributes to the dissemination of cutting-edge research in the field. He as over 128 Publications some of which include: Loop | Babak Saboury

Artificial Intelligence and Pet Imaging, Part I – PET Clinics

Objective Task-Based Evaluation of Artificial Intelligence-Based Medical Imaging Methods – PET Clinics

https://www.pet.theclinics.com/article/S1556-8598(21)00055-9/fulltext

Professional Affiliations and Recognitions

Dr. Saboury is a Diplomate of the American Board of Radiology and the American Board of Nuclear Medicine. His commitment to integrating clinical informatics into medical practice has earned him recognition as a leader in the field. He has been featured in various professional platforms, including UroToday and GU Oncology Now, where he has shared insights on PSMA-targeted therapies and the future of prostate cancer treatment.

SNMMI Task Force Outlines Challenges, and Considerations in Artificial Intelligence | GU Oncology Now

Contact Information

(12) Babak Saboury | LinkedIn

Dr. Saboury at United Theranostics – Bethesda, located at:

5454 Wisconsin Avenue, Suite 1600,
Bethesda, MD 20815

Phone: (301) 450-2588

Website: www.unitedtheranostics.com

Dr. Babak Saboury’s career embodies a commitment to innovation, precision, and patient-centered care in nuclear medicine. Through his leadership at United Theranostics, extensive research contributions, and dedication to education, he continues to shape the future of nuclear medicine and radiopharmaceutical therapy.